NR1H4 and colorectal carcinoma: The more substantial anti-proliferative effect of Compound 5a in the SW620 cells than its effect in HT29 cells was consistent with a previous study reporting the different levels of CRC cell chemosensitivity to GW4064, a synthetic farnesoid X receptor agonist (Guo et al., 2021).